Icosavax, Inc.
NASDAQ:ICVX
15.31 (USD) • At close February 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Assets: | ||||
| Current Assets: | ||||
| Cash & Cash Equivalents
| 58.846 | 279.082 | 13.114 | 23.079 |
| Short Term Investments
| 159.461 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 218.307 | 279.082 | 13.114 | 23.079 |
| Net Receivables
| 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 |
| Other Current Assets
| 4.545 | 5.829 | 0.662 | 0.209 |
| Total Current Assets
| 223.913 | 286.553 | 16.16 | 23.288 |
| Non-Current Assets: | ||||
| Property, Plant & Equipment, Net
| 14.764 | 1.076 | 0.01 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| -14.764 | -1.076 | -0.01 | 0 |
| Total Non-Current Assets
| 14.764 | 1.076 | 0.01 | 0 |
| Total Assets
| 238.677 | 287.629 | 16.17 | 23.288 |
| Liabilities & Equity: | ||||
| Current Liabilities: | ||||
| Account Payables
| 2.892 | 3.899 | 1.918 | 0.799 |
| Short Term Debt
| 2.137 | 0 | 0 | 0 |
| Tax Payables
| 0.08 | 0 | 0.091 | 0.001 |
| Deferred Revenue
| 0 | 0.582 | 2.384 | 0 |
| Other Current Liabilities
| 8.759 | 4.757 | 1.532 | 0.424 |
| Total Current Liabilities
| 13.788 | 9.238 | 5.834 | 1.223 |
| Non-Current Liabilities: | ||||
| Long Term Debt
| 6.658 | 0 | 4.947 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.069 | 0.171 | 32.092 | 30.308 |
| Total Non-Current Liabilities
| 6.727 | 0.171 | 37.039 | 30.308 |
| Total Liabilities
| 20.515 | 9.409 | 42.873 | 31.531 |
| Equity: | ||||
| Preferred Stock
| 0 | 287.629 | 30.062 | 30.062 |
| Common Stock
| 0.006 | 0.005 | 0.002 | 0.001 |
| Retained Earnings
| -185.827 | -94.069 | -27.098 | -8.244 |
| Accumulated Other Comprehensive Income/Loss
| -0.403 | -287.629 | 0 | 0 |
| Other Total Stockholders Equity
| 404.386 | 372.284 | -29.669 | -30.062 |
| Total Shareholders Equity
| 218.162 | 278.22 | -26.703 | -8.243 |
| Total Equity
| 218.162 | 278.22 | -26.703 | -8.243 |
| Total Liabilities & Shareholders Equity
| 238.677 | 287.629 | 16.17 | 23.288 |